Meiji

Success for AZ, setback for Sanofi in type 1 diabetes

AZ’s drug has also been filed in the US, along with Japan, so it will be interesting to see how the FDA handles that marketing application when it delivers a

UCB looks to pipeline with five years left for twin blockbusters

However in January finally gained recommendation from an expert committee at the US regulator, with FDA approval expected soon, and with Japan already granting approval. ... it leaves the EU, pointing to Japan’s rising prominence, thanks to its success

McCann Health's next challenge: creative differentiation

There are plans to implement the scheme in three major hubs – London, New York and Japan.

As government rushes through no-deal legislation, UK biotech repeats Brexit plea

two’ of markets after the US, EU and Japan.It found that 45% of marketing authorisation applications submitted to the EMA during 2013-2015 had not been submitted to these three

Immuno-oncology in 2019: the rapid evolution continues

BMS led the charge when Opdivo became the first in its class to gain approval (in metastatic melanoma in December 2014 in Japan), but Merck &Co’s Keytruda has emerged as

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]